ARCHIVES

NCI’s caBIG to Expand For Clinical Informatics Projects.

This article is from The Cancer Letter archive.

Vol. 33 No. 03 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

Broder: Downward Negotiations Or Coercion? NCI Authorities

June 15, 1990

In Brief: CREG To Be Used In Viral Oncology, Nutrition, Cell Kinetics, Immunology, Rauscher Tells NCAB

April 4, 1975

Maxine Singer Wins Top SES Award

January 8, 1988

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

December 5, 2014